knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 21:27:27 - browse：4152

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： FDA endorses new sterilization method for medical devices

WSS

The inclusion problem at the heart of rehabilitation research

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Stigma and the return of syphilis

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Future doctors need a strong humanities education

High breast density mammograms need follow

knowledge

knowledge

hotspot

Alkermes shareholders re

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Peter Hotez and the public health issue of online harassment

Focused ultrasound for uterine fibroids: an uphill battle

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What will save rural psychiatry services? Higher Medicaid payments

BioMarin wins approval for gene therapy to treat hemophilia A

Dark money group runs ads on China biotech bill

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What will save rural psychiatry services? Higher Medicaid payments

hotspot

iTeos Therapeutics debuts first data on TIGIT

Do more moles mean more problems? Not so, says new study

Future doctors need a strong humanities education

First Opinion Podcast: What happens when kids become caregivers?

Dog Aging Project founders on what lies ahead after losing funding

Antibiotic resistance nearly killed me, so I'm raising awareness of it

explore

entertainment

focus

hotspot